Stepan (SCL) EBITDA (2010 - 2025)

Stepan (SCL) has 16 years of EBITDA data on file, last reported at -$55.5 million in Q4 2025.

• For the quarter ending Q4 2025, EBITDA fell 820.82% year-over-year to -$55.5 million; the trailing twelve-month figure through Dec 2025 stood at $12.6 million (down 82.15% YoY), and the FY2025 full-year result was $12.6 million, down 82.15% from the prior year.
• EBITDA for Q4 2025 stood at -$55.5 million, down from $21.8 million in the prior quarter.
• Across five years, EBITDA topped out at $77.6 million in Q2 2022 and bottomed at -$156.0 million in Q4 2022.
• The 5-year median for EBITDA is $20.6 million (2023), against an average of $17.6 million.
• The widest annual swing landed in 2022, when EBITDA slumped 880.2%; it then soared 3245.65% in 2024.
• A 5-year view of EBITDA shows it stood at $20.0 million in 2021, then plunged by 880.2% to -$156.0 million in 2022, then surged by 100.15% to $230000.0 in 2023, then jumped by 3245.65% to $7.7 million in 2024, then slumped by 820.82% to -$55.5 million in 2025.
• The last three EBITDA figures came in at -$55.5 million (Q4 2025), $21.8 million (Q3 2025), and $18.0 million (Q2 2025), per Business Quant data.

Peer Comparison